SUPPLEMENTAL INDENTURE

EX-10.309 12 ex-10309supp_indenturex6x0.htm SUPPLEMENTAL INDENTURE 6.00% 2023 NOTES Exhibit
Exhibit 10.309


SUPPLEMENTAL INDENTURE
SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of September 30, 2015, among Par Pharmaceutical Companies, Inc., a Delaware corporation, Par Pharmaceutical, Inc., a Delaware corporation, Anchen Incorporated, a Delaware corporation, Par, Inc., a Delaware corporation, Anchen Pharmaceuticals, Inc., a California corporation, JHP Group Holdings, Inc., a Delaware corporation, JHP Acquisition, LLC, a Delaware limited liability company, Par Sterile Products, LLC, a Delaware limited liability company, Kali Laboratories, Inc., a New Jersey corporation, Innoteq, Inc., a Connecticut corporation, Par Laboratories Europe, Ltd., a company organized under the laws of the United Kingdom and Endo Finance IV Limited, a private limited company incorporated under the laws of Ireland (each, a “Guaranteeing Subsidiary and collectively, the “Guaranteeing Subsidiaries”), subsidiaries of Endo Designated Activity Company, a private limited company incorporated under the laws of Ireland (the “Company”), the Issuers, the other Guarantors (both, as defined in the Indenture referred to below) and Wells Fargo Bank, National Association, as trustee under the Indenture referred to below (the “Trustee”).

W I T N E S S E T H
WHEREAS, the Company, Endo Finance LLC, a Delaware limited liability company, and Endo Finco Inc., a Delaware corporation, have heretofore executed and delivered to the Trustee an indenture, dated as of July 9, 2015(the “Indenture”), providing for the issuance of 6.000% Senior Notes due 2023 (the “Notes”);
WHEREAS, the Indenture provides that under certain circumstances the Guaranteeing Subsidiaries shall execute and deliver to the Trustee a supplemental indenture pursuant to which the Guaranteeing Subsidiaries shall unconditionally guarantee all of the Issuers’ Obligations under the Notes and the Indenture on the terms and conditions set forth herein (the “Note Guarantee”);
WHEREAS, this Supplemental Indenture has not resulted in a material modification of the Notes for Foreign Account Tax Compliance Act purposes; and
WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.
NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Guaranteeing Subsidiaries and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:
1.CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.
2.AGREEMENT TO GUARANTEE. Each of the Guaranteeing Subsidiaries hereby agrees to provide an unconditional Guarantee on the terms and subject to the conditions set forth in the Note Guarantee and in the Indenture including but not limited to Article 10 thereof.
3.NO RECOURSE AGAINST OTHERS. No director, officer, employee, incorporator or stockholder of the Issuers or any Guarantor, as such, will have any liability for any obligations of the Issuers or the Guarantors under the Notes, this Supplemental Indenture, the Note Guarantees

    

Exhibit 10.309


or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder of Notes by accepting a Note waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Notes. The waiver may not be effective to waive liabilities under the federal securities laws.
4.NEW YORK LAW TO GOVERN; WAIVER OF JURY TRIAL. THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. EACH OF THE ISSUERS AND THE GUARANTORS CONSENTS AND IRREVOCABLY SUBMITS TO THE JURISDICTION OF ANY NEW YORK STATE OR U.S. FEDERAL COURT LOCATED IN THE BOROUGH OF MANHATTAN, CITY OF NEW YORK, COUNTY OF NEW YORK, STATE OF NEW YORK IN RELATION TO ANY LEGAL ACTION OR PROCEEDING (I) ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS INDENTURE, AS SUPPLEMENTED, THE NOTES, THE GUARANTEES AND ANY RELATED DOCUMENTS AND/OR (II) ARISING UNDER ANY U.S. FEDERAL OR U.S. STATE SECURITIES LAWS IN RESPECT OF THE NOTES, THE GUARANTEES AND ANY SECURITIES ISSUED PURSUANT TO THE TERMS OF THE INDENTURE, AS SUPPLEMENTED. EACH OF THE ISSUERS AND THE GUARANTORS WAIVES ANY OBJECTION TO PROCEEDINGS IN ANY SUCH COURTS, WHETHER ON THE GROUND OF VENUE OR ON THE GROUND THAT THE PROCEEDINGS HAVE BEEN BROUGHT IN AN INCONVENIENT FORUM. EACH OF THE GUARANTEEING SUBSIDIARIES, TO THE EXTENT ORGANIZED OUTSIDE OF THE UNITED STATES, SHALL APPOINT CT CORPORATION SYSTEM, 111 EIGHTH AVENUE, 13TH FLOOR, NEW YORK, NY 10011, AS ITS AGENT FOR SERVICE OF PROCESS IN ANY SUCH SUIT, ACTION OR PROCEEDING AND AGREES THAT SERVICE OF PROCESS UPON SAID AUTHORIZED AGENT SHALL BE DEEMED IN EVERY RESPECT EFFECTIVE SERVICE OF PROCESS UPON IT IN ANY SUCH SUIT, ACTION OR PROCEEDING. EACH OF THE GUARANTEEING SUBSIDIARIES AGREES TO DELIVER, UPON THE EXECUTION AND DELIVERY OF THIS SUPPLEMENTAL INDENTURE, A WRITTEN ACCEPTANCE BY SUCH AGENT OF ITS APPOINTMENT AS SUCH AGENT. EACH OF GUARANTEEING SUBSIDIARIES, TO THE EXTENT ORGANIZED OUTSIDE OF THE UNITED STATES, FURTHER AGREES TO TAKE ANY AND ALL ACTION, INCLUDING THE FILING OF ANY AND ALL SUCH DOCUMENTS AND INSTRUMENTS, AS MAY BE REASONABLY NECESSARY TO CONTINUE SUCH DESIGNATION AND APPOINTMENT OF CT CORPORATION SYSTEM IN FULL FORCE AND EFFECT FOR SO LONG AS THE INDENTURE, AS SUPPLEMENTED, REMAINS IN FORCE. EACH OF THE ISSUERS, THE TRUSTEE AND THE GUARANTORS HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE NOTES OR THE TRANSACTIONS CONTEMPLATED HEREBY.
5.COUNTERPARTS. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy (which may be provided via facsimile or other electronic transmission) shall be an original, but all of them together represent the same agreement.
6.EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

2


Exhibit 10.309


7.THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Guaranteeing Subsidiaries and the Issuers.
[Signature Pages Follow]

3


Exhibit 10.309


IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.
PAR PHARMACEUTICAL COMPANIES, INC.
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
PAR PHARMACEUTICAL, INC.
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
ANCHEN INCORPORATED
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
PAR, INC.
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 



[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


JHP GROUP HOLDINGS, INC
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
JHP ACQUISITION, LLC
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
PAR STERILE PRODUCTS, LLC
as a Guaranteeing Subsidiary
by JHP ACQUISITION, LLC, as Manager
by JHP GROUP HOLDINGS, INC., its manager
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 


[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


ANCHEN PHARMACEUTICALS, INC
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 


[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


KALI LABORATORIES, INC.
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 


[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


INNOTEQ, INC.
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 





[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


PAR LABORATORIES EUROPE, LTD
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Orla Dunlea
 
Name:
Orla Dunlea
 
Title:
Director
 

[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


ENDO FINANC IV LIMITED
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Orla Dunlea
 
Name:
Orla Dunlea
 
Title:
Director
 

[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


ENDO FINCO INC.
as an Issuer
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Secretary
 


[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


ENDO DESIGNATED ACTIVITY COMPANY
as a Issuer
 
 
 
 
 
 
 
 
By:
/s/
Orla Dunlea
 
Name:
Orla Dunlea
 
Title:
Director
 


[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


ENDO FINANCE LLC
as an Issuer
by ENDO LUXEMBOURG FINANCE COMPANY I S.À R.L., its sole member
 
 
 
 
 
 
 
 
By:
/s/
John D. Boyle
 
Name:
John D. Boyle
 
Title:
A Manager
 
 
 
 
 
 
 
 
 
By:
/s/
Joost Tulkens
 
Name:
Joost Tulkens
 
Title:
B Manager
 




[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


ENDO LLC
ENDO U.S. INC.
each, as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Secretary
 


[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


DAVA PHARMACEUTICALS, INC.
ENDO HEALTH SOLUTIONS, INC.
ENDO PHARMACEUTICALS INC.
ENDO PHARMACEUTICALS SOLUTIONS INC.
ENDO PHARMACEUTICALS VALERA INC.
GENERICS INTERNATIONAL (US PARENT), INC.
GENERICS INTERNATIONAL (US MIDCO), INC.
GENERICS INTERNATIONAL (US HOLDO), INC.
GENERICS INTERNATIONAL (US), INC.
AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.each, as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 


[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


GENERICS BIDCO I, LLC
VINTAGE PHARMACEUTICALS, LLC
GENERICS BIDCO II, LLC
MOORES MILL PROPERTIES LLC
WOOD PARK PROPERTIES LLC
QUARTZ SPECIALITY PHARMACEUTICALS, LLC
each as a Guarantor
by GENERICS INTERNATIONAL (US), INC.,
its manager
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 



[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


LEDGEMENT ROYALTY SUB LLC
each as a Guarantor
by ENDO PHARMACEUTICALS SOLUTIONS INC.,
its manager
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 


[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


DAVA International, LLC
as a Guarantor
by DAVA PHARMACEUTICALS, INC.,
its sole member
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
DAVA CAPITAL MANAGEMENT, INC.
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 




























[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309




AUXILIUM INTERNATIONAL HOLDINGS, INC.
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
SLATE PHARMACEUTICALS, INC.
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
TIMM MEDICAL TECHNOLOGIES, INC.
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
ACTIENT PHARMACEUTICALS LLC
as a Guarantor
 
 
 
 
By: AUXILIUM PHARMACEUTICALS, INC.,
its manager
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 



[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309



ACTIENT THERAPEUTICS LLC
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
AUXILIUM US HOLDINGS, LLC
as a Guarantor
 
 
 
 
By: AUXILIUM PHARMACEUTICALS, INC.,
its manager
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
AUXILIUM PHARMACEUTICALS, INC.
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 




[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


70 MAPLE AVENUE, LLC
as a Guarantor
 
 
 
 
By: ACTIENT PHARMACEUTICALS LLC,
its manager
 
 
 
By: AUXILIUM PHARMACEUTICALS, INC
its manager
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
TIMM MEDICAL HOLDINGS, LLC
its Guarantor
 
By: ACTIENT PHARMACEUTICALS LLC,
its manager
 
By: AUXILIUM PHARMACEUTICALS, INC.
its manager
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
APHRODITE WOMEN'S HEALTH, LLC
as a Guarantor
 
By: AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.,
its manager
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 

[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309




[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309



ENDO MANAGEMENT LIMITED
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Orla Dunlea    
 
Name:
Orla Dunlea    
 
Title:
Director
 
 
 
 
ENDO VENTURES LIMITED
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Orla Dunlea    
 
Name:
Orla Dunlea    
 
Title:
Director
 
 
 
 
ENDO MANAGEMENT II LIMITED
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Orla Dunlea    
 
Name:
Orla Dunlea    
 
Title:
Director
 
 
 
 
 
 
 
 
 
 
 
 
 
ENDO FINANCE III LIMITED
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Orla Dunlea    
 
Name:
Orla Dunlea    
 
Title:
Director
 




[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


HAWK ACQUISITION IRELAND LIMITED
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Orla Dunlea    
 
Name:
Orla Dunlea    
 
Title:
Director
 
 
 
 
 
 
 
 
 
ENDO TOPFIN LIMITED
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Orla Dunlea    
 
Name:
Orla Dunlea    
 
Title:
Director
 


[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


ENDO IRELAND FINANCE LIMITED
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Orla Dunlea    
 
Name:
Orla Dunlea    
 
Title:
Director
 


[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


PALADIN LABS CANADIAN HOLDING INC.
as a Guarantor
 
 
 
 
By:
/s/
Mark Beaudet
 
Name:
Mark Beaudet
 
Title:
President
 
 
 
 
PALADIN LABS INC.
as a Guarantor
 
 
 
 
By:
/s/
Mark Beaudet
 
Name:
Mark Beaudet
 
Title:
President
 



[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


ENDO VENTURES BERMUDA LIMITED
as a Guarantor
 
 
 
 
By:
/s/
Susan Hall
 
Name:
Susan Hall
 
Title:
Director
 
 
 
 
ENDO GLOBAL VENTURES
as a Guarantor
 
 
 
 
By:
/s/
Susan Hall
 
Name:
Susan Hall
 
Title:
Director
 
 
 
 
 
 
 
 
 
 
 
 
 
HAWK ACQUISITION ULC
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Laurence S. Smith
 
Name:
Laurence S. Smith
 
Title:
Director
 
 
 
 
 
 
 
 
 
 
 
 
 
ENDO BERMUDA FINANCE LIMITED
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Robert J. Cobuzzi.
 
Name:
Robert J. Cobuzzi.
 
Title:
Director
 


[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


ENDO NETHERLANDS B.V.
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Robert J. Cobuzzi.
 
Name:
Robert J. Cobuzzi.
 
Title:
Managing Director A
 
 
 
 
 
 
 
 
 
By:
/s/
Gert Jan Rietberg
 
Name:
Gert Jan Rietberg
 
Title:
Managing Director B
 


[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


ENDO VENTURES CYPRUS LIMITED
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Orla Dunlea
 
Name:
Orla Dunlea
 
Title:
Director
 


[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


AUXILIUM UK LTD
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
Orla Dunlea
 
Name:
Orla Dunlea
 
Title:
Director
 

[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


ENDO LUXEMBOURG HOLDING COMPANY S.À R.L.
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
John D. Boyle
 
Name:
John D. Boyle
 
Title:
A Manager
 
 
 
 
 
By:
/s/
Joost Tulkens
 
Name:
Joost Tulkens
 
Title:
B Manager
 
 
 
 
 
 
 
 
 
 
 
 
 
ENDO LUXEMBOURG FINANCE COMPANY I S.À R.L.
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
John D. Boyle
 
Name:
John D. Boyle
 
Title:
A Manager
 
 
 
 
 
By:
/s/
Joost Tulkens
 
Name:
Joost Tulkens
 
Title:
B Manager
 
 
 
 
 
 
 
 
 
 
 
 
 
ENDO LUXEMBOURG FINANCE COMPANY II S.À R.L.
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
John D. Boyle
 
Name:
John D. Boyle
 
Title:
A Manager
 
 
 
 
 
By:
/s/
Joost Tulkens
 
Name:
Joost Tulkens
 
Title:
B Manager
 

[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


ENDO US HOLDINGS LUXEMBOURG I HOLDING COMPANY S.À R.L.
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
John D. Boyle
 
Name:
John D. Boyle
 
Title:
A Manager
 
 
 
 
 
 
 
 
 
By:
/s/
Joost Tulkens
 
Name:
Joost Tulkens
 
Title:
B Manager
 
 
 
 
 
 
 
 
 
 
 
 
 
ENDO US HOLDINGS LUXEMBOURG II S.À R.L.
as a Guarantor
 
 
 
 
 
 
 
 
By:
/s/
John D. Boyle
 
Name:
John D. Boyle
 
Title:
A Manager
 
 
 
 
 
 
 
 
 
By:
/s/
Joost Tulkens
 
Name:
Joost Tulkens
 
Title:
B Manager
 

[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]

Exhibit 10.309


WELLS FARGO BANK, NATIONAL ASSOCIATION,
as a Trustee
 
 
 
 
 
 
 
 
By:
/s/
Yana Kislenko
 
Name:
Yana Kislenko
 
Title:
Vice President
 


[Signature Page to 6.000% Notes due 2023 Supplemental Indenture]